Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Gut-Brain Axis01:22

Gut-Brain Axis

11
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
11
Neural Regulation01:37

Neural Regulation

44.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.1K
Neurotransmitters01:31

Neurotransmitters

3.2K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
3.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

897
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
897

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Halogen-Controlled Aromatic Interactions Drive the Self-Assembly and Mechanics of Peptide Hydrogels.

ACS applied bio materials·2026
Same author

Helix-Aggregation Interplay in Nucleophosmin 1: Structural, Morphological, and Cytotoxic Consequences of Fragment Length.

ACS omega·2026
Same author

SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacement.

European journal of pharmacology·2026
Same author

Structure-Guided SOCS3 Peptidomimetics: Design and Functional Characterization.

ACS omega·2026
Same author

Rational design of η<sup>6</sup>-arene Ru(II) complexes for amyloid-β targeting: influence of coordination lability and aromaticity.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Gold Nanoparticles Enhance Radiosensitivity in Glioblastoma Cells.

ACS omega·2026
Same journal

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders).

Recent patents on CNS drug discovery·2016
Same journal

Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.

Recent patents on CNS drug discovery·2016
Same journal

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.

Recent patents on CNS drug discovery·2016
Same journal

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response.

Recent patents on CNS drug discovery·2016
Same journal

Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents.

Recent patents on CNS drug discovery·2016
Same journal

Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders.

Recent patents on CNS drug discovery·2016
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

640

Endocannabinoid System in Neurological Disorders.

Roberta Ranieri, Chiara Laezza, Maurizio Bifulco

  • 1Department of Medicine and Surgery, University of Salerno, Via Salvatore Allende, Baronissi, 84081 Salerno, Italy and Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 84084 Fisciano (Salerno)- Italy. annamaria.malfitano@unina.it.

Recent Patents on CNS Drug Discovery
|July 2, 2016
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system shows neuroprotective properties and may be a therapeutic target for neurodegenerative diseases. Cannabinoids offer potential in managing conditions like Alzheimer's and Parkinson's disease.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.0K

Related Experiment Videos

Last Updated: Mar 18, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

640
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

3.0K

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The endocannabinoid system (ECS) and related drugs show therapeutic promise for various diseases.
  • These include neurological disorders, atherosclerosis, stroke, cancer, and metabolic syndrome.

Purpose of the Study:

  • To review ECS signaling and its role in neurodegenerative diseases.
  • To discuss the therapeutic potential of cannabinoids in these conditions.

Main Methods:

  • Literature review of ECS signaling pathways.
  • Analysis of cannabinoid interventions in neurodegenerative disease models.
  • Examination of CB1 and CB2 receptor functions.

Main Results:

  • Neurodegenerative diseases share common mechanisms: neuro-inflammation, excitotoxicity, and mitochondrial dysfunction.
  • The ECS modulates Ca2+ homeostasis, trophic support, and inflammation.
  • Cannabinoid-based therapies may offer a valid treatment option for neurodegeneration.

Conclusions:

  • The endocannabinoid system exhibits neuroprotective effects.
  • The ECS represents a promising therapeutic target for neurodegenerative diseases.